Towards a cell-based treatment for androgenetic alopecia in men and women: 12-month interim safety results of a phase 1/2a clinical trial using autologous dermal sheath cup cell injections

被引：0
|
作者：
McElwee, K. [1 ]
Panich, D. [1 ]
Hall, D. [1 ]
Hoffmann, R. [1 ]
机构：
[1] RepliCel Life Sci Inc, Vancouver, BC, Canada
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2013年 / 133卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：1401 / 1401
页数：1
相关论文
共 3 条
  • [1] Phase I/IIa clinical trial for the treatment of androgenetic alopecia using intradermal injections of cultured autologous dermal sheath cup cells
    McElwee, K.
    Lortkipanidze, N.
    Panich, D.
    Buckler, L.
    Hoffmann, R.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (10) : S241 - S241
  • [2] MVX-ONCO-1: First in man, Phase I clinical trial combining encapsulation cell technology and irradiated autologous tumor cells for personalized cell-based immunotherapy. Safety, feasibility and clinical outcome results
    Migliorini, D.
    Vernet, R.
    Belkouch, M. C.
    Luy, P.
    Blaser, S.
    Ancrenaz, V.
    Blazek, N.
    Grandjean, N.
    Wasem, J.
    Janin, B.
    Harboe-Schmidt, P.
    Grogg, J.
    Bouche, N.
    Mach, N.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S114 - S114
  • [3] Stem cell therapy in diabetic men with erectile dysfunction: a 24-month follow-up of safety and efficacy of two intracavernous autologous bone marrow derived mesenchymal stem cells injections, an open label phase 2 clinical trial
    Al Demour, Saddam
    Adwan, Sofia
    Jafar, Hanan
    Alhawari, Hussam
    Awidi, Abdalla
    BASIC AND CLINICAL ANDROLOGY, 2024, 34 (01)
1